QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,174 signal articles · 359 in last 24h · 110,767 total before filter · latest 27m ago
359last 24h
2378last 7d
429● bullish (7d)
221● bearish (7d)
202publishers
AllMacro259Earnings1446M&A99Regulatory17Product17Analyst22
✕ clear all filtersticker: PMSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Philip Morris (PM) Bets $1.2B on ZYN as BAT (BTI) Steps Up Its Pouch Push
Insider Monkey5d agoneutral
Philip Morris (PM) Bets $1.2B on ZYN as BAT (BTI) Steps Up Its Pouch Push

Philip Morris International (NYSE:PM) just turned a $600 million plan into a $1.2 billion one. On July 27, the company opened its Aurora, Colorado manufacturing campus, a 780,000-square-foot facility built to produce ZYN nicotine pouches. The site went from groundbreaking to commercial shipments in about 19 months, and it opened just weeks after regulators handed […]

Philip Morris International (PM) Opens Its Largest US Manufacturing Campus For ZYN
Simply Wall St.6d agoneutral
Philip Morris International (PM) Opens Its Largest US Manufacturing Campus For ZYN

Philip Morris International opened a new manufacturing campus in Aurora, Colorado, its largest investment in the U.S. to date. The facility expands domestic production capacity for modern nicotine products, including nicotine pouches sold under the ZYN brand. The Aurora campus is fully integrated, supporting production, logistics, and distribution for the company’s U.S. operations. For investors tracking Philip Morris International, NYSE:PM, the Aurora opening adds context to a stock that...

Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?
Simply Wall St.6d agobearish
Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?

Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...

Altria Group (MO): A Winner in President Trump’s Stock Portfolio?
Insider Monkey14d agoneutral
Altria Group (MO): A Winner in President Trump’s Stock Portfolio?

Altria Group (NYSE:MO) sells cigarettes, oral nicotine pouches, and vapor products to adult tobacco users in the US. It’s the parent of Marlboro, still the country’s top-selling cigarette brand. The stock showed up in Donald Trump’s disclosed portfolio, and it’s easy to see the appeal: over 50 straight years of dividend increases and a business […]

Why Did Philip Morris (PM) Rise After Cutting Its 2026 Profit Forecast Again?
Insider Monkey15d agoneutral
Why Did Philip Morris (PM) Rise After Cutting Its 2026 Profit Forecast Again?

Philip Morris International Inc. (NYSE:PM) cut its 2026 adjusted earnings forecast for the third time this year on July 22. Nevertheless, the shares rose about 5% in early trading and closed 3.33% higher at $194.30. The market appears to have looked through the guidance reduction for two reasons. First, the cut reflected a smaller expected currency […]

Philip Morris International (PM) Wins FDA Modified Risk Status For ZYN In The US
Simply Wall St.16d agobullish
Philip Morris International (PM) Wins FDA Modified Risk Status For ZYN In The US

FDA authorizes Philip Morris International's ZYN nicotine pouches as modified risk tobacco products in the US. ZYN becomes the first and only smoke free nicotine pouch with this regulatory status in the US market. The decision recognizes PMI's harm reduction science and sets a new benchmark for smoke free alternatives. Philip Morris International (NYSE:PM) is expanding its smoke free portfolio, and the FDA's modified risk approval for ZYN puts a fresh spotlight on that shift. The company...

Is Philip Morris International (PM) Fairly Valued After Its 5 Year Run?
Simply Wall St.17d agoneutral
Is Philip Morris International (PM) Fairly Valued After Its 5 Year Run?

Philip Morris International stock has delivered a very strong 143.6% total return over the past 5 years, yet current valuation checks and an intrinsic value estimate that sits close to the market price suggest the shares no longer look obviously cheap or clearly stretched either. A 143.6% return over 5 years highlights how much value the market has already priced into Philip Morris International, which naturally raises the bar for any further gains. Expectations around the growth and...

2 Cash-Producing Stocks on Our Buy List and 1 We Ignore
StockStory18d agobullish
2 Cash-Producing Stocks on Our Buy List and 1 We Ignore

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Philip Morris International Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Philip Morris International Q2 Earnings Call Highlights

Philip Morris International (NYSE:PM) reported what management described as a “very strong” second quarter, with growth led by its international smoke-free products business and a better-than-expected performance in combustibles. Emmanuel Babeau, the company’s group chief financial officer, said Ph